Robert Hosse, MD
Pulmonary Disease · Baton Rouge, LANPI 1447791686
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $282, 6.2 times the $45 reported in 2020. That places this record below the midpoint for pulmonary disease clinicians in LA, where the typical reported total is $3,696.
Across 19 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols USA, LLC$52
- Insmed, Inc.$45
- Boehringer Ingelheim$40
- AstraZeneca$39
- Sanofi$37
- AbbVie$31
- plus $164 from 8 others
What the payments were for
- Food & beverage$39196%
- Education$174%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols USA, LLC | 2 | $52 |
| Insmed, Inc. | 2 | $45 |
| Boehringer Ingelheim | 2 | $40 |
| AstraZeneca | 2 | $39 |
| Sanofi | 1 | $37 |
| AbbVie | 2 | $31 |
| Merck | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Viatris Specialty LLC | 1 | $23 |
| GSK | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Philips North America LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
How this compares
$409 in reported general payments places this provider in the 20th percentile of 189 pulmonary disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Baton Rouge
- Hollis O NealBaton Rouge$418K
- Robert HinkleBaton Rouge$19K
- Tarek AbdallahBaton Rouge$12K
- Alexander MulamulaBaton Rouge$12K
- Brad VincentBaton Rouge$12K
- Andrea EspinozaHouma$655K
- Joseph LaskyNew Orleans$447K
- Ramsy AbdelghaniNew Orleans$308K
- Juzar AliNew Orleans$216K
- Warren BotnickNatchitoches$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.